FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3037188045> ?p ?o ?g. }

• W3037188045 endingPage "764" @default.
• W3037188045 startingPage "755" @default.
• W3037188045 abstract "Opioid-induced respiratory depression (OIRD) is a potentially fatal complication associated with conventional opioids. Currently, there is a paucity of validated endpoints available to measure respiratory safety. Oliceridine, an investigational intravenous (IV) opioid, is a G-protein selective μ-agonist with limited activity on β-arrestin2, a signaling pathway associated with adverse events including OIRD. In controlled phase III trials, oliceridine 0.35 mg and 0.5 mg demand doses demonstrated comparable analgesia to morphine 1 mg with favorable improvements in respiratory safety. In this exploratory analysis, we report dosing interruption (DI) and average cumulative duration of DI (CDDI) for both oliceridine and morphine. Patients requiring analgesia after bunionectomy or abdominoplasty were randomized to IV demand doses of placebo, oliceridine (0.1 mg, 0.35 mg, or 0.5 mg), or morphine (1 mg), administered via patient-controlled analgesia (PCA), following a loading dose (oliceridine 1.5 mg, morphine 4 mg, volume-matched placebo) with a 6-min lockout interval. Certified nurse anesthetists monitored each patient and withheld study medication according to the patient’s respiratory status. For each patient, the duration of all DIs was summed and reported as CDDI. A zero-inflated gamma mixture model was used to compute the mean CDDI for each treatment. Proportion of patients with DI was lower with oliceridine (0.1 mg: 3.2%, 0.35 mg: 13.9%, 0.5 mg: 15.1%) versus morphine (22%). The CDDI was also lower across all demand doses of oliceridine versus morphine. Using DI as a surrogate for OIRD indicates improved respiratory safety with oliceridine versus morphine that merits further investigation." @default.
• W3037188045 created "2020-07-02" @default.
• W3037188045 creator A5027476747 @default.
• W3037188045 creator A5032847432 @default.
• W3037188045 creator A5044099105 @default.
• W3037188045 creator A5049281279 @default.
• W3037188045 creator A5065801628 @default.
• W3037188045 creator A5074477898 @default.
• W3037188045 creator A5078128383 @default.
• W3037188045 date "2020-06-24" @default.
• W3037188045 modified "2023-10-14" @default.
• W3037188045 title "Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain" @default.
• W3037188045 cites W1131840578 @default.
• W3037188045 cites W1991187412 @default.
• W3037188045 cites W2107153432 @default.
• W3037188045 cites W2132468342 @default.
• W3037188045 cites W2134939120 @default.
• W3037188045 cites W2137887442 @default.
• W3037188045 cites W2147602656 @default.
• W3037188045 cites W2162263830 @default.
• W3037188045 cites W2165671231 @default.
• W3037188045 cites W2551249668 @default.
• W3037188045 cites W2761456602 @default.
• W3037188045 cites W2767985039 @default.
• W3037188045 cites W2770319189 @default.
• W3037188045 cites W2803943598 @default.
• W3037188045 cites W2809005610 @default.
• W3037188045 cites W2898251267 @default.
• W3037188045 cites W2903733020 @default.
• W3037188045 cites W2921387917 @default.
• W3037188045 cites W2948334509 @default.
• W3037188045 cites W2963998010 @default.
• W3037188045 cites W3017361310 @default.
• W3037188045 cites W4237559255 @default.
• W3037188045 doi "https://doi.org/10.1007/s40261-020-00936-0" @default.
• W3037188045 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7359152" @default.
• W3037188045 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32583295" @default.
• W3037188045 hasPublicationYear "2020" @default.
• W3037188045 type Work @default.
• W3037188045 sameAs 3037188045 @default.
• W3037188045 citedByCount "26" @default.
• W3037188045 countsByYear W30371880452020 @default.
• W3037188045 countsByYear W30371880452021 @default.
• W3037188045 countsByYear W30371880452022 @default.
• W3037188045 countsByYear W30371880452023 @default.
• W3037188045 crossrefType "journal-article" @default.
• W3037188045 hasAuthorship W3037188045A5027476747 @default.
• W3037188045 hasAuthorship W3037188045A5032847432 @default.
• W3037188045 hasAuthorship W3037188045A5044099105 @default.
• W3037188045 hasAuthorship W3037188045A5049281279 @default.
• W3037188045 hasAuthorship W3037188045A5065801628 @default.
• W3037188045 hasAuthorship W3037188045A5074477898 @default.
• W3037188045 hasAuthorship W3037188045A5078128383 @default.
• W3037188045 hasBestOaLocation W30371880451 @default.
• W3037188045 hasConcept C126322002 @default.
• W3037188045 hasConcept C142724271 @default.
• W3037188045 hasConcept C151032500 @default.
• W3037188045 hasConcept C170493617 @default.
• W3037188045 hasConcept C197934379 @default.
• W3037188045 hasConcept C204787440 @default.
• W3037188045 hasConcept C27081682 @default.
• W3037188045 hasConcept C2776029756 @default.
• W3037188045 hasConcept C2777288759 @default.
• W3037188045 hasConcept C2777389121 @default.
• W3037188045 hasConcept C2780820201 @default.
• W3037188045 hasConcept C2781063702 @default.
• W3037188045 hasConcept C42219234 @default.
• W3037188045 hasConcept C71924100 @default.
• W3037188045 hasConceptScore W3037188045C126322002 @default.
• W3037188045 hasConceptScore W3037188045C142724271 @default.
• W3037188045 hasConceptScore W3037188045C151032500 @default.
• W3037188045 hasConceptScore W3037188045C170493617 @default.
• W3037188045 hasConceptScore W3037188045C197934379 @default.
• W3037188045 hasConceptScore W3037188045C204787440 @default.
• W3037188045 hasConceptScore W3037188045C27081682 @default.
• W3037188045 hasConceptScore W3037188045C2776029756 @default.
• W3037188045 hasConceptScore W3037188045C2777288759 @default.
• W3037188045 hasConceptScore W3037188045C2777389121 @default.
• W3037188045 hasConceptScore W3037188045C2780820201 @default.
• W3037188045 hasConceptScore W3037188045C2781063702 @default.
• W3037188045 hasConceptScore W3037188045C42219234 @default.
• W3037188045 hasConceptScore W3037188045C71924100 @default.
• W3037188045 hasIssue "8" @default.
• W3037188045 hasLocation W30371880451 @default.
• W3037188045 hasLocation W30371880452 @default.
• W3037188045 hasLocation W30371880453 @default.
• W3037188045 hasLocation W30371880454 @default.
• W3037188045 hasOpenAccess W3037188045 @default.
• W3037188045 hasPrimaryLocation W30371880451 @default.
• W3037188045 hasRelatedWork W1565257393 @default.
• W3037188045 hasRelatedWork W1974413519 @default.
• W3037188045 hasRelatedWork W1977519830 @default.
• W3037188045 hasRelatedWork W2085215752 @default.
• W3037188045 hasRelatedWork W2130211844 @default.
• W3037188045 hasRelatedWork W2280346282 @default.
• W3037188045 hasRelatedWork W2409945781 @default.
• W3037188045 hasRelatedWork W2473665131 @default.
• W3037188045 hasRelatedWork W600243788 @default.

• next